The Influence of Socioeconomic Factors on Access to Biologics in Psoriasis.
Jenny M NorlinSofia LöfvendahlMarcus Schmitt-EgenolfPublished in: Journal of clinical medicine (2023)
The higher-income group had better access to biologics than the middle-income group when adjusting for disease severity and lifestyle factors. This may not only be an equity problem, as a better allocation of society's resources might have resulted in a higher overall effectiveness of biologics.